Kranus Health
Kranus Health is a digital therapeutics company focused on providing virtual care in urology. They offer solutions for erectile dysfunction, voiding dysfunction, incontinence in women, and uro-oncology. The company aims to revolutionize healthcare through technology, enabling better patient and doctor journeys. Kranus Health emphasizes a culture of innovation, data-driven decision-making, and a commitment to patient well-being. They are actively expanding their offerings and global presence, with offices in Germany and Paris, and are supported by a medical advisory board of renowned physicians.
Kranus Health
Kranus Health is a digital therapeutics company focused on providing virtual care in urology. They offer solutions for erectile dysfunction, voiding dysfunction, incontinence in women, and uro-oncology. The company aims to revolutionize healthcare through technology, enabling better patient and doctor journeys. Kranus Health emphasizes a culture of innovation, data-driven decision-making, and a commitment to patient well-being. They are actively expanding their offerings and global presence, with offices in Germany and Paris, and are supported by a medical advisory board of renowned physicians.
TL;DR
What they do: Prescription digital therapeutics for urology (e.g., Kranus Edera for erectile dysfunction)
Founded: 2020
Funding to date: USD 21,300,000 (reported total funding)
Geographic presence: Germany (Berlin/Munich) and expanded into France
Regulatory/reimbursement: DiGA listing and reimbursable in Germany
Company Overview
Problem Domain
Urology: erectile dysfunction, voiding dysfunction, female incontinence, uro‑oncology
Founded
2020
Industry
Digital health / Digital therapeutics
Funding Track Record
Seed investors included HTGF, A Round Capital, Venture Basecamp and business angels
6500000.00
Series A announced June 20, 2022; company reported total funding ~USD 8M at that time
Series A expansion increased reported cumulative funding to ~USD 15M
Most recent Series A round announced Mar 25, 2024; recent lead investors named include CapHorn Invest and Future Positive Capital
Investor Signal
“Backed by VC firms, family offices and angel investors including Karista, HTGF, A Round Capital, Peak Pride, SwissHealth Ventures, CapHorn Invest, and Future Positive Capital”